These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 26215385)
21. Effect of hormone therapy on mortality rates among women with heart failure and coronary artery disease. Bibbins-Domingo K; Lin F; Vittinghoff E; Barrett-Connor E; Hulley SB; Grady D; Shlipak MG Am J Cardiol; 2005 Jan; 95(2):289-91. PubMed ID: 15642574 [TBL] [Abstract][Full Text] [Related]
22. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience. Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160 [TBL] [Abstract][Full Text] [Related]
23. An angiotensin receptor blocker reduces the risk of congestive heart failure in elderly hypertensive patients with renal insufficiency. Nakamura T; Kanno Y; Takenaka T; Suzuki H; Hypertens Res; 2005 May; 28(5):415-23. PubMed ID: 16156505 [TBL] [Abstract][Full Text] [Related]
24. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure. Ivanes F; Susen S; Mouquet F; Pigny P; Cuilleret F; Sautière K; Collet JP; Beygui F; Hennache B; Ennezat PV; Juthier F; Richard F; Dallongeville J; Hillaert MA; Doevendans PA; Jude B; Bertrand M; Montalescot G; Van Belle E Eur Heart J; 2012 Jan; 33(2):191-202. PubMed ID: 21719456 [TBL] [Abstract][Full Text] [Related]
25. Acute coronary syndrome and khat herbal amphetamine use: an observational report. Ali WM; Al Habib KF; Al-Motarreb A; Singh R; Hersi A; Al Faleh H; Asaad N; Al Saif S; Almahmeed W; Sulaiman K; Amin H; Al-Lawati J; Al Bustani N; Al-Sagheer NQ; Al-Qahtani A; Al Suwaidi J Circulation; 2011 Dec; 124(24):2681-9. PubMed ID: 22155995 [TBL] [Abstract][Full Text] [Related]
26. Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study. Leening MJ; Ferket BS; Steyerberg EW; Kavousi M; Deckers JW; Nieboer D; Heeringa J; Portegies ML; Hofman A; Ikram MA; Hunink MG; Franco OH; Stricker BH; Witteman JC; Roos-Hesselink JW BMJ; 2014 Nov; 349():g5992. PubMed ID: 25403476 [TBL] [Abstract][Full Text] [Related]
27. Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE). Kasanuki H; Hagiwara N; Hosoda S; Sumiyoshi T; Honda T; Haze K; Nagashima M; Yamaguchi J; Origasa H; Urashima M; Ogawa H; Eur Heart J; 2009 May; 30(10):1203-12. PubMed ID: 19346521 [TBL] [Abstract][Full Text] [Related]
28. Predictors of long-term clinical endpoints in patients with refractory angina. Povsic TJ; Broderick S; Anstrom KJ; Shaw LK; Ohman EM; Eisenstein EL; Smith PK; Alexander JH J Am Heart Assoc; 2015 Jan; 4(2):. PubMed ID: 25637344 [TBL] [Abstract][Full Text] [Related]
29. Outcomes among 3.5 million newly diagnosed hypertensive Canadians. Quan H; Chen G; Tu K; Bartlett G; Butt DA; Campbell NR; Hemmelgarn BR; Hill MD; Johansen H; Khan N; Lix LM; Smith M; Svenson L; Walker RL; Wielgosz A; McAlister FA; Can J Cardiol; 2013 May; 29(5):592-7. PubMed ID: 23465341 [TBL] [Abstract][Full Text] [Related]
30. Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease. Mack MJ; Head SJ; Holmes DR; Ståhle E; Feldman TE; Colombo A; Morice MC; Unger F; Erglis A; Stoler R; Dawkins KD; Serruys PW; Mohr FW; Kappetein AP JACC Cardiovasc Interv; 2013 Apr; 6(4):344-54. PubMed ID: 23523456 [TBL] [Abstract][Full Text] [Related]
31. Impact of visit-to-visit variability and systolic blood pressure control on subsequent outcomes in hypertensive patients with coronary artery disease (from the HIJ-CREATE substudy). Arashi H; Ogawa H; Yamaguchi J; Kawada-Watanabe E; Hagiwara N Am J Cardiol; 2015 Jul; 116(2):236-42. PubMed ID: 25966826 [TBL] [Abstract][Full Text] [Related]
32. Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study). Schopfer DW; Ku IA; Regan M; Whooley MA Am Heart J; 2014 Feb; 167(2):186-192.e1. PubMed ID: 24439979 [TBL] [Abstract][Full Text] [Related]